Tag: Dr. Jonathan Wall


Wall Appointed A University Distinguished Professor at UTHSC

|

Jonathan Wall, PhD, a professor at the University of Tennessee Health Science Center’s Graduate School of Medicine (GSM) in Knoxville, has been appointed as a University Distinguished Professor. The title is reserved for those who have contributed in a superlative way to UTHSC and brought distinction and respect to the university. Dr. Wall’s appointment comes… Read More


UTHSC’s Jonathan Wall Receives $1.79 Million To Develop New Amyloidosis Treatment

|

The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.” Amyloidosis is a rare disease that occurs when abnormal protein… Read More


UTHSC’s Jonathan Wall Awarded $385,000 Grant To Study Amyloidosis Treatment Options

|

Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville and director of the Amyloidosis and Cancer Theranostics, has been awarded a two-year grant totaling $385,000 from the National Institute on Aging, part of the National Institutes of Health to study new treatments for systemic amyloidosis. “Our… Read More


Researcher Jonathan Wall, PhD, with The University of Tennessee Health Science Center Receives $1 Million to Study Antibody Therapy for Systemic Amyloid Disease

|

The amyloidoses are a group of rare diseases that are a consequence of abnormal protein (amyloid) deposits in various body tissues and organs. Characterized as systemic or localized, light chain-associated amyloidosis (AL) is the most common form of systemic amyloid disease, with an estimated 4,500 new cases each year in the United States. Systemic amyloid… Read More